Jeff Yass’s Ingevity NGVT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-12,200
| Closed | -$582K | – | 12843 |
|
|
2024
Q1 | $582K | Sell |
12,200
-2,500
| -17% | -$112K | ﹤0.01% | 8142 |
|
|
2023
Q4 | $694K | Sell |
14,700
-3,900
| -21% | -$162K | ﹤0.01% | 7857 |
|
|
2023
Q3 | $886K | Buy |
18,600
+11,100
| +148% | +$606K | ﹤0.01% | 6900 |
|
|
2023
Q2 | $436K | Buy |
+7,500
| New | +$450K | ﹤0.01% | 8629 |
|
|
2023
Q1 | – | Sell |
-3,200
| Closed | -$225K | – | 13173 |
|
|
2022
Q4 | $225K | Sell |
3,200
-4,200
| -57% | -$296K | ﹤0.01% | 9823 |
|
|
2022
Q3 | $449K | Buy |
7,400
+4,200
| +131% | +$282K | ﹤0.01% | 8775 |
|
|
2022
Q2 | $202K | Sell |
3,200
-2,800
| -47% | -$182K | ﹤0.01% | 10610 |
|
|
2022
Q1 | $384K | Buy |
6,000
+3,200
| +114% | +$214K | ﹤0.01% | 9650 |
|
|
2021
Q4 | $201K | Sell |
2,800
-5,900
| -68% | -$449K | ﹤0.01% | 11437 |
|
|
2021
Q3 | $621K | Sell |
8,700
-400
| -4% | -$31.5K | ﹤0.01% | 8829 |
|
|
2021
Q2 | $740K | Sell |
9,100
-7,200
| -44% | -$579K | ﹤0.01% | 8600 |
|
|
2021
Q1 | $1.23M | Sell |
16,300
-8,400
| -34% | -$612K | ﹤0.01% | 7173 |
|
|
2020
Q4 | $1.87M | Sell |
24,700
-18,200
| -42% | -$1.19M | ﹤0.01% | 5239 |
|
|
2020
Q3 | $2.12M | Hold |
42,900
| – | – | ﹤0.01% | 4502 |
|
|
2020
Q2 | $2.25M | Buy |
42,900
+28,900
| +206% | +$1.37M | ﹤0.01% | 4285 |
|
|
2020
Q1 | $493K | Buy |
14,000
+2,700
| +24% | +$158K | ﹤0.01% | 6966 |
|
|
2019
Q4 | $987K | Buy |
11,300
+1,000
| +10% | +$87.4K | ﹤0.01% | 5557 |
|
|
2019
Q3 | $874K | Buy |
10,300
+7,000
| +212% | +$624K | ﹤0.01% | 5973 |
|
|
2019
Q2 | $347K | Sell |
3,300
-25,400
| -89% | -$2.55M | ﹤0.01% | 8029 |
|
|
2019
Q1 | $3.03M | Sell |
28,700
-3,800
| -12% | -$382K | ﹤0.01% | 3108 |
|
|
2018
Q4 | $2.72M | Buy |
32,500
+18,800
| +137% | +$1.7M | ﹤0.01% | 3068 |
|
|
2018
Q3 | $1.4M | Sell |
13,700
-600
| -4% | -$57.9K | ﹤0.01% | 4614 |
|
|
2018
Q2 | $1.16M | Sell |
14,300
-7,000
| -33% | -$556K | ﹤0.01% | 5032 |
|
|
2018
Q1 | $1.57M | Buy |
21,300
+11,600
| +120% | +$868K | ﹤0.01% | 4368 |
|
|
2017
Q4 | $684K | Buy |
9,700
+5,800
| +149% | +$418K | ﹤0.01% | 6001 |
|
|
2017
Q3 | $244K | Buy |
+3,900
| New | +$231K | ﹤0.01% | 7720 |
|
|
2017
Q2 | – | Sell |
-8,300
| Closed | -$505K | – | 9603 |
|
|
2017
Q1 | $505K | Buy |
+8,300
| New | +$469K | ﹤0.01% | 6471 |
|
Other funds holding NGVT
SBH
RA
Jeff Yass's NGVT Position: Q2 2026 in Review
Jeff Yass reduced its Ingevity (NGVT) stake by 74% in Q2 2026, selling an estimated $3.08M and leaving 14,879 shares worth $1.11M. The position accounts for ﹤0.01% of the portfolio, ranked #7930.
Jeff Yass first reported a position in NGVT in Q4 2016 and has held it in 33 quarters since. The position peaked at $30.1M in Q1 2019. 313 funds tracked by Wall St. Rank hold NGVT as of Q2 2026.
- Jeff Yass held 14,879 shares of Ingevity worth $1.11M as of Q2 2026.
- Jeff Yass sold 42,731 Ingevity shares in Q2 2026, an estimated $3.08M.
- Ingevity made up ﹤0.01% of Jeff Yass's portfolio in Q2 2026, its #7930 holding.
- Jeff Yass first reported a position in Ingevity in Q4 2016 and has held it in 33 quarters since.
- Jeff Yass's Ingevity position peaked at $30.1M in Q1 2019.
- 313 funds tracked by Wall St. Rank held Ingevity as of Q2 2026.
Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.